Triamcinolone acetonide 55 ug Spray, Metered
by CARDINAL HEALTH 110, LLC. DBA LEADER · 1 BOTTLE, SPRAY in 1 CARTON (70000-0702-1) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY
NDC 70000-0702-01
🏷️ FDA NDC (as labeled)
70000-0702-1
billing pads the package segment with a zero
OTC
Generic
Discontinued
Non-controlled
⚠ Discontinued by firm
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Triamcinolone Acetonide (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Sep 28, 2023 — Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial. (Eugia US LLC) · FDA recall D-0041-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
⚠️
Excluded from the active FDA NDC Directory.
The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Jun 2025. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory.
Search the FDA NDC Directory ↗
🆔 Identity & classification
FDA NDC (as labeled)
70000-0702-1
Product NDC
70000-0702
11-digit billing NDC
70000070201
RxCUI
1797913
UNII
F446C597KA
Application #
ANDA214615
SPL Set ID
c8000539-125f-f0dd-2f69-580eea235a77
Established class (EPC)
Corticosteroid
Mechanism of action
Corticosteroid Hormone Receptor Agonists
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
Discontinued
FDA listing status
Discontinued by firm (certified through Jun 2025)
Marketing start
2025-06-03
Route
NASAL
Dosage form
SPRAY, METERED
Substance
TRIAMCINOLONE ACETONIDE
GCN Seq No
072054
GCN
36145
HICL code
002891
Ingredient (HICL)
Triamcinolone Acetonide
HIC1 code
Q
Therapeutic class — broad (HIC1)
Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code
Q7
Therapeutic class — intermediate (HIC2)
Nasal Preparations
HIC3 code
Q7P
Therapeutic class — specific (HIC3)
Nasal Anti-Inflammatory Steroids
AHFS code
48:10.08.00
AHFS class
Corticosteroids (Respiratory Tract)
FDB label name
TRIAMCINOLONE 55 MCG NASAL SPR
FDB brand name
Triamcinolone Acetonide
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 70000-0702-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0702-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Corticosteroid class.
Pharmacologic class
Corticosteroid
Drug family (ATC)
Corticosteroids for local oral treatment, Corticosteroids, Corticosteroids, moderately potent (group II)
How it works
Corticosteroid Hormone Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerCARDINAL HEALTH 110, LLC. DBA LEADER
Application holderAPOTEX INC
FDA applicationANDA214615 (ANDA)
Labeler code70000
First marketedJun 2025
Product typeHuman Otc Drug
Portfolio163 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name TRIAMCINOLONE 55 MCG NASAL SPR Ingredient Triamcinolone Acetonide
📗 Our plain-language guide HelloPharmacist
- Yes, intra-articular triamcinolone is specifically approved to give short-term relief for knee arthritis, gout flares, bursitis, and similar joint conditions. The extended-release...
- I'm getting a triamcinolone injection in my knee. Will it actually help, and how long does it last?
- That's a really important thing to flag with your doctor before your injection or prescription. Triamcinolone can raise blood sugar — even in people whose diabetes is well-controll...
- I have diabetes. Should I be worried about using triamcinolone?
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Triamcinolone Acetonide — tap one for details:
8
Nutrient depletion considerations
Triamcinolone Acetonide may be associated with lower levels of 8 nutrients — worth a chat with your pharmacist, not a cause for alarm.
ZINC
Insignificant Depletion
CALCIUM
Moderate Depletion
CHROMIUM
Moderate Depletion
MAGNESIUM
Moderate Depletion
POTASSIUM
Moderate Depletion
+3 more
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Triamcinolone acetonide?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.739 | — |
| Medicaid paysCMS SDUD · 12 mo | $1.40 | — |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per mL) — tap or hover for the price & month
▲ Up 1% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Good Sense Nasal Allergy 55 ug 00113-0443-01 | L. | 1 bottle | $0.739 | — | Availability likely | — |
| Nasal Allergy 55 ug 00536-1457-69 | Rugby | 1 bottle | $0.739 | — | Availability likely | — |
| Triamcinolone Acetonide Nasal 55 ug 45802-0109-01 | Padagis | 1 bottle | $0.739 | — | Availability likely | — |
| Good Neighbor Pharmacy 24 Hour Nasal Allergy 55 ug 46122-0385-76 | Amerisource | 1 bottle | $0.739 | — | Availability likely | — |
| Triamcinolone acetonide 55 ug 60505-6275-07 | Apotex | 1 bottle | $0.739 | — | Availability likely | — |
| Triamcinolone acetonide 55 ugthis 70000-0702-01 | CARDINAL | 1 bottle | $0.739 | — | Discontinued | — |
| Triamcinolone Acetonide 55 ug 70000-0742-01 | CARDINAL | 1 bottle | $0.739 | — | Availability likely | — |
| foster and thrive 24 hour nasal allergy 55 ug 70677-1023-01 | Strategic | 1 bottle | $0.739 | — | Availability likely | — |
| Allergy Nasal 55 ug 00363-0811-01 | Walgreen | 1 bottle | — | — | FDA listed | — |
| Up and Up Nasal Allergy 55 ug 11673-0717-01 | Target | 1 bottle | — | — | FDA listed | — |
| Nasal Allergy 55 ug 11822-0443-01 | Rite | 1 bottle | — | — | Discontinued | — |
| Signature Care Nasal Allergy 55 ug 21130-0443-01 | Safeway | 1 bottle | — | — | FDA listed | — |
| Nasal Allergy 55 ug 21130-0613-02 | Safeway | 1 bottle | — | — | FDA listed | — |
| Nasal Allergy Relief 55 ug 30142-0665-01 | Kroger | 1 bottle | — | — | FDA listed | — |
| nasal allergy 55 ug 30142-0813-01 | Kroger | 1 bottle | — | — | FDA listed | — |
| Topcare Nasal Allergy 55 ug 36800-0621-01 | Topco | 1 bottle | — | — | FDA listed | — |
| Nasal Allergy 55 ug 37808-0443-01 | H | 1 bottle | — | — | FDA listed | — |
| Equaline nasal allergy 55 ug 41163-0443-01 | United | 1 bottle | — | — | FDA listed | — |
| Nasacort Allergy 24HR 55 ug 41167-5800-01 | Chattem, | 1 bottle | — | — | FDA listed | — |
| 24 Hour Nasal Allergy 55 ug 41250-0443-01 | Meijer | 1 bottle | — | — | FDA listed | — |
| CareOne Allergy Relief 55 ug 41520-0443-01 | American | 1 bottle | — | — | Discontinued | — |
| Equate Nasal Allergy 55 ug 49035-0443-01 | Wal-Mart | 1 bottle | — | — | FDA listed | — |
| Nasacort 55 ug 50090-1444-00 | A-S | 1 bottle | — | — | FDA listed | — |
| allergy relief 55 ug 51316-0711-01 | CVS | 1 bottle | — | — | FDA listed | — |
| DG Health Nasal Allergy 55 ug 55910-0280-02 | Dolgencorp, | 1 bottle | — | — | FDA listed | — |
| Nasal Allergy 55 ug 59779-0746-01 | CVS | 1 bottle | — | — | FDA listed | — |
| Triamcinolone acetonide 55 ug 69168-0482-01 | Allegiant | 1 bottle | — | — | FDA listed | — |
| Triamcinolone Acetonide Nasal 55 ug 72162-2289-02 | Bryant | 1 bottle | — | — | FDA listed | — |
| Basic Care Nasal Allergy 55 ug 72288-0443-01 | Amazon.com | 1 bottle | — | — | FDA listed | — |
| Nasal Allergy 55 ug 42507-0443-01 | HyVee | 1 bottle | — | — | FDA listed | — |
| Triamcinolone Acetonide 55 ug 58602-0035-07 | Aurohealth | 1 bottle | — | — | FDA listed | — |
| Childrens Triamcinolone Acetonide 55 ug 58602-0037-11 | Aurohealth | 1 bottle | — | — | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2025
On the market since
Jun 2025
📍
2026
Currently FDA-listed
1 year listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 70000-0702-01, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q3 2025 – Q4 2025 · 2 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
33
Units reimbursed last 4 qtrs
608
Gross reimbursed last 4 qtrs
$850.08
Avg / prescription
$25.76
Avg / unit
$1.3972
Latest quarter Q4 2025
33Rx
Medicaid pays / mL
$1.3972
gross reimbursed
vs
NADAC / mL
$0.7388
acquisition cost
=
Spread
+$0.6584
+89% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 33 Rx Managed care · 0 Rx
State Medicaid map
Units reimbursed · per 100k residents
1.61.6
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Triamcinolone Acetonide — the program that covers self-administered drugs. 22 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Triamcinolone Acetonide. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$17.79M
Claims incl. refills
1.7M
Beneficiaries
1.4M
Spend / beneficiary
$13.01
Spend / claim
$10.45
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Triamcinolone Acetonide — the ingredient across all brands.
Top reported reactions
Reporter sex
Male · 34%
Female · 66%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 70000-0702-01 You're viewing this | 1 BOTTLE, SPRAY in 1 CARTON (70000-0702-1) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY | 2025-06-03 | Discontinued by firm |
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | ✓ Available |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | ✓ Available |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 70000-0702-1, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 70000-0702-01, written without dashes as 70000070201. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 70000-0702-01, the first segment (70000) is the labeler code FDA assigned to CARDINAL HEALTH 110, LLC. DBA LEADER; the middle segment (0702) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Who lists this product with the FDA?
CARDINAL HEALTH 110, LLC. DBA LEADER is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion runny nose sneezing itchy nose
⏱️ Dosage and Administration ▾
Directions Read insert (inside package) on how to: get a new bottle ready (primed) before first use prime bottle again if not used for more than 2 weeks use the spray clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older once daily, spray 2 times into each nostril while sniffing gently once your allergy symptoms improve, reduce to 1 spray in each nostril per day. CHILDREN 2 TO UNDER 12 YEARS OF AGE the growth rate of some children may be slower while using this product.
Talk to your child’s doctor if your child needs to use the spray longer than two months a year. children 6 to under 12 years of age an adult should supervise use once daily, spray 1 time into each nostril while sniffing gently if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day. children 2 to under 6 years of age an adult should supervise use once daily, spray 1 time into each nostril while sniffing gently children under 2 years of age do not use do not use more than directed if you forget a dose, do not double the next dose do not spray into eyes or mouth if allergy symptoms do not improve after one week, stop using and talk to a doctor do not use for the common cold shake well before each use
⚠️ Warnings ▾
Warnings Do not use In children under 2 years of age If you have ever had an allergic reaction to any of the ingredients Ask a doctor before use if you have had recent nose ulcers or nose surgery have had a nose injury that has not healed are using a steroid medicine for asthma, allergies or skin rash have an eye infection have or had glaucoma or cataracts When using this product the growth rate of some children may be slower some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief. do not share this bottle with anyone else as this may spread germs remember to tell your doctor about all the medicines you take, including this one Stop use and ask a doctor if you have, or come in contact with someone who has, chickenpox, measles or tuberculosis you have or develop symptoms of an infection such as persistent fever you have any change in vision you have severe or frequent nosebleeds If pregnant or breast-feeding , ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
🧪 Active Ingredient ▾
Active ingredient (in each spray) Triamcinolone acetonide 55 mcg (glucocorticoid)
🧪 Inactive Ingredients ▾
Inactive ingredients benzalkonium chloride solution (50% W/V) carboxymethylcellulose sodium, dextrose monohydrate, edetate disodium dihydrate, hydrochloric acid, microcrystalline cellulose, polysorbate 80 purified water & sodium hydroxide
🎯 Purpose ▾
Purpose Allergy symptom reliever
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.